Bryn Mawr Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.03M | Buy |
11,252
+1,051
| +10% | +$564K | 0.33% | 75 |
|
|
2025
Q1 | $4.28M | Sell |
10,201
-12
| -0.1% | -$5.04K | 0.26% | 92 |
|
|
2024
Q4 | $4.22M | Sell |
10,213
-409
| -4% | -$169K | 0.23% | 95 |
|
|
2024
Q3 | $5.37M | Sell |
10,622
-23
| -0.2% | -$11.6K | 0.29% | 81 |
|
|
2024
Q2 | $5.19M | Sell |
10,645
-10
| -0.1% | -$4.87K | 0.29% | 82 |
|
|
2024
Q1 | $5.75M | Sell |
10,655
-23
| -0.2% | -$12.4K | 0.33% | 76 |
|
|
2023
Q4 | $5.93M | Buy |
10,678
+80
| +0.8% | +$44.4K | 0.37% | 70 |
|
|
2023
Q3 | $4.63M | Buy |
+10,598
| New | +$4.63M | 0.3% | 76 |
|